Transdisciplinary approaches enhance the production of translational knowledge

Translational Research

Volumn 182, Issue , 2017, Pages 123-134

  Ciesielski, Timothy H ^a,b,c   Aldrich, Melinda C ^d   Marsit, Carmen J ^b   Hiatt, Robert A ^e   Williams, Scott M ^a,b  

^a DARTMOUTH COLLEGE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c REGIS COLLEGE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

XENOBIOTIC AGENT;

DECISION MAKING; EXPLORATORY RESEARCH; GENOME-WIDE ASSOCIATION STUDY; HEALTH SERVICE; HUMAN; INTERPERSONAL COMMUNICATION; LEARNING; MACHINE LEARNING; METHODOLOGY; PRIORITY JOURNAL; REVIEW; TRANSLATIONAL RESEARCH; WORK ENVIRONMENT; ANIMAL; BIOLOGICAL MODEL; EPIDEMIOLOGIST; INTERDISCIPLINARY COMMUNICATION;

ANIMALS; DECISION MAKING; EPIDEMIOLOGISTS; HUMANS; INTERDISCIPLINARY COMMUNICATION; MODELS, BIOLOGICAL; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85009477137     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2016.11.002     Document Type: Review

References (98)

1. 1 Hiatt, R.A., Sulsky, S., Aldrich, M.C., et al. Promoting innovation and creativity in epidemiology for the 21st century. Ann Epidemiol 23 (2013), 452–454.
2. 2 McKeown, R.E., Is epidemiology correcting its vision problem? A perspective on our perspective: 2012 presidential address for American College of Epidemiology. Ann Epidemiol 23 (2013), 603–607.
3. 3 Ness, R.B., Tools for innovative thinking in epidemiology. Am J Epidemiol 175 (2012), 733–738.
4. 4 Is Integrative Cancer Epidemiology the Next-Gen of Epidemiology?: Epidemiology and Genomics Research Program of the National Cancer Institute's Division of Cancer Control and Population Sciences, 2014 http://blog-epi.grants.cancer.gov/2013/08/13/integrative-cancer-epidemiology/ Accessed June 27, 2014.
5. 5 Khoury, M.J., Lam, T.K., Ioannidis, J.P., et al. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev 22 (2013), 508–516.
6. 6 Spitz, M.R., Caporaso, N.E., Sellers, T.A., Integrative cancer epidemiology–the next generation. Cancer Discov 2 (2012), 1087–1090.
7. 7 Lam, T.K., Spitz, M., Schully, S.D., et al. “Drivers” of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev 22 (2013), 181–188.
8. 8 Wuchty, S., Jones, B.F., Uzzi, B., The increasing dominance of teams in production of knowledge. Science 316 (2007), 1036–1039.
9. 9 Lynch, J., It's not easy being interdisciplinary. Int J Epidemiol 35 (2006), 1119–1122.
10. 10 Frerichs, R.R., John Snow. 2014 http://www.ph.ucla.edu/epi/snow.html#PUMP%20HANDLE Accessed June 23, 2014.
11. 11 Rosenfield, P.L., The potential of transdisciplinary research for sustaining and extending linkages between the health and social sciences. Social Sci Med 35 (1992), 1343–1357.
12. 12 Stokols, D., Hall, K.L., Taylor, B.K., et al. The science of team science: overview of the field and introduction to the supplement. Am J Prev Med 35 (2008), S77–S89.
13. 13 Hall, K.L., Vogel, A.L., Stipelman, B., et al. A four-phase model of transdisciplinary team-based research: Goals, team processes, and strategies. Translational Behav Med 2 (2012), 415–430.
14. 14 Vineis, P., Kriebel, D., Causal models in epidemiology: past inheritance and genetic future. Environ Health, 5, 2006, 21.
15. 15 Hennekens, C.H., Buring, J.E., Chapter 2 design strategies in epidemiologic research. Mayrent, S.L., (eds.) Epidemiology in Medicine, 1, 1987, Lippincott Williams & Wilkins, Philadelphia, PA, 16–29.
16. 16 Rothman, K.J., Causes. Am J Epidemiol 104 (1976), 587–592.
17. 17 Ritchie, M.D., Hahn, L.W., Roodi, N., et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69 (2001), 138–147.
18. 18 Moore JH. 2014. Available at: http://www.epistasis.org/index-3.html. Accessed June 25, 2014.
19. 19 Moore, J.H., Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn 4 (2004), 795–803.
20. 20 Park, H.W., Shin, E.S., Lee, J.E., et al. Multilocus analysis of atopy in Korean children using multifactor-dimensionality reduction. Thorax 62 (2007), 265–269.
21. 21 Collins, R.L., Hu, T., Wejse, C., et al. Multifactor dimensionality reduction reveals a three-locus epistatic interaction associated with susceptibility to pulmonary tuberculosis. BioData Min, 6, 2013, 4.
22. 22 Afzal, S., Gusella, M., Jensen, S.A., et al. The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer. Pharmacogenomics 12 (2011), 1257–1267.
23. 23 Bastone, L., Reilly, M., Rader, D.J., et al. MDR and PRP: a comparison of methods for high-order genotype-phenotype associations. Hum Hered 58 (2004), 82–92.
24. 24 Ritchie, M.D., Hahn, L.W., Moore, J.H., Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 24 (2003), 150–157.
25. 25 Gui, J., Moore, J.H., Williams, S.M., et al. A simple and computationally efficient approach to multifactor dimensionality reduction analysis of gene-gene interactions for quantitative traits. PLoS One, 8, 2013, e66545.
26. 26 Lou, X.Y., Chen, G.B., Yan, L., et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet 80 (2007), 1125–1137.
27. 27 Heidema, A.G., Feskens, E.J., Doevendans, P.A., et al. Analysis of multiple SNPs in genetic association studies: comparison of three multi-locus methods to prioritize and select SNPs. Genet Epidemiol 31 (2007), 910–921.
28. 28 Andrew, A.S., Karagas, M.R., Nelson, H.H., et al. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum Hered 65 (2008), 105–118.
29. 29 Ihsan, R., Chauhan, P.S., Mishra, A.K., et al. Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer. PLoS One, 6, 2011, e29431.
30. 30 Su, M.W., Tung, K.Y., Liang, P.H., et al. Gene-gene and gene-environmental interactions of childhood asthma: a multifactor dimension reduction approach. PLoS One, 7, 2012, e30694.
31. 31 Hu, T., Sinnott-Armstrong, N.A., Kiralis, J.W., et al. Characterizing genetic interactions in human disease association studies using statistical epistasis networks. BMC Bioinformatics, 12, 2011, 364.
32. 32 Hu, T., Chen, Y., Kiralis, J.W., et al. An information-gain approach to detecting three-way epistatic interactions in genetic association studies. J Am Med Inform Assoc 20 (2013), 630–636.
33. 33 Yee, J., Kwon, M.S., Park, T., et al. A modified entropy-based approach for identifying gene-gene interactions in case-control study. PLoS One, 8, 2013, e69321.
34. 34 Moore, J.H., Lari, R.C., Hill, D., et al. Human microbiome visualization using 3D technology. Pac Symp Biocomput, 2011, 154–164.
35. 35 Hu, T., Chen, Y., Kiralis, J.W., et al. ViSEN: methodology and software for visualization of statistical epistasis networks. Genet Epidemiol 37 (2013), 283–285.
36. 36 Galea, S., Riddle, M., Kaplan, G.A., Causal thinking and complex system approaches in epidemiology. Int J Epidemiol 39 (2010), 97–106.
37. 37 Auchincloss, A.H., Diez Roux, A.V., A new tool for epidemiology: the usefulness of dynamic-agent models in understanding place effects on health. Am J Epidemiol 168 (2008), 1–8.
38. 38 Diez Roux, A.V., Integrating social and biologic factors in health research: a systems view. Ann Epidemiol 17 (2007), 569–574.
39. 39 Hiatt, R.A., Porco, T.C., Liu, F., et al. A multi-level model of postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev 23 (2014), 2078–2092.
40. 40 Marshall, B.D., Galea, S., Formalizing the role of agent-based modeling in causal inference and epidemiology. Am J Epidemiol 181 (2015), 92–99.
41. 41 Hernan, M.A., Invited commentary: agent-based models for causal inference-reweighting data and theory in epidemiology. Am J Epidemiol 181 (2015), 103–105.
42. 42 Diez Roux, A.V., Invited commentary: the virtual epidemiologist-promise and peril. Am J Epidemiol 181 (2015), 100–102.
43. 43 Marshall, B.D., Galea, S., Marshall and Galea respond to “data theory in epidemiology”. Am J Epidemiol 181 (2015), 106–107.
44. 44 Howards, P.P., Schisterman, E.F., Poole, C., et al. “Toward a clearer definition of confounding” revisited with directed acyclic graphs. Am J Epidemiol 176 (2012), 506–511.
45. 45 Hernandez-Diaz, S., Schisterman, E.F., Hernan, M.A., The birth weight “paradox” uncovered?. Am J Epidemiol 164 (2006), 1115–1120.
46. 46 Greenland, S., Pearl, J., Robins, J.M., Causal diagrams for epidemiologic research. Epidemiology 10 (1999), 37–48.
47. 47 Khoury, M.J., Ioannidis, J.P., Medicine. Big data meets public health. Science 346 (2014), 1054–1055.
48. 48 Kraft, P., Curses–winner's and otherwise–in genetic epidemiology. Epidemiology 19 (2008), 649–651 discussion 57–8.
49. 49 Kraft, P., Zeggini, E., Ioannidis, J.P., Replication in genome-wide association studies. Stat Sci 24 (2009), 561–573.
50. 50 Vineis, P., Brennan, P., Canzian, F., et al. Expectations and challenges stemming from genome-wide association studies. Mutagenesis 23 (2008), 439–444.
51. 51 Williams, S.M., Canter, J.A., Crawford, D.C., et al. Problems with genome-wide association studies. Science 316 (2007), 1840–1842.
52. 52 Greene, C.S., Penrod, N.M., Williams, S.M., et al. Failure to replicate a genetic association may provide important clues about genetic architecture. PLoS One, 4, 2009, e5639.
53. 53 Williams, S.M., Haines, J.L., Correcting away the hidden heritability. Ann Hum Genet 75 (2011), 348–350.
54. 54 Ciesielski, T.H., Pendergrass, S.A., White, M.J., et al. Diverse convergent evidence in the genetic analysis of complex disease: coordinating omic, informatic, and experimental evidence to better identify and validate risk factors. BioData Min, 7, 2014, 10.
55. 55 Jallow, M., Teo, Y.Y., Small, K.S., et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 41 (2009), 657–665.
56. 56 Timmann, C., Thye, T., Vens, M., et al. Genome-wide association study indicates two novel resistance loci for severe malaria. Nature 489 (2012), 443–446.
57. 57 Saxena, R., Voight, B.F., Lyssenko, V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007), 1331–1336.
58. 58 Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 (2007), 1341–1345.
59. 59 Zeggini, E., Weedon, M.N., Lindgren, C.M., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316 (2007), 1336–1341.
60. 60 IOM. Bridging the Evidence Gap in Obesity Prevention: A Framework to Inform Decision Making. 2010, National Academy of Sciences, Washington DC.
61. 61 Chatterji, M., Green, L.W., Kumanyika, S., L.E.A.D.: a framework for evidence gathering and use for the prevention of obesity and other complex public health problems. Health Educ Behav 41 (2014), 85–99.
62. 62 The Cochrane Collaboration. Available at: http://www.cochrane.org/. Accessed September 8, 2014.
63. 63 Hemila, H., Chalker, E., Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev, 1, 2013, CD000980.
64. 64 Hemilä, H., Chalker, E., Vitamin C for preventing and treating the common cold. 2015, John Wiley & Sons, Ltd, Hoboken, NJ Available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000980.pub4/abstract Accessed March 17, 2015.
65. 65 IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2014 Available at: http://monographs.iarc.fr/ Accessed September 8, 2014.
66. 66 Rooney, A.A., Boyles, A.L., Wolfe, M.S., et al. Systematic review and evidence integration for literature-based environmental health science assessments. Environ Health Perspect 122 (2014), 711–718.
67. 67 Databases, Searches & Other Resources: The National Toxicology Program, 2014, U.S. Department of Health and Human Services Available at: http://ntp.niehs.nih.gov/results/dbsearch/index.html Accessed September 24, 2014.
68. 68 Bellinger, D.C., Lead neurotoxicity and socioeconomic status: conceptual and analytical issues. Neurotoxicology 29 (2008), 828–832.
69. 69 Wild, C.P., Future research perspectives on environment and health: the requirement for a more expansive concept of translational cancer research. Environ Health, 10 Suppl 1, 2011, S15.
70. 70 Rappaport, S.M., Implications of the exposome for exposure science. J Expo Sci Environ Epidemiol 21 (2011), 5–9.
71. 71 Igl, W., Johansson, A., Wilson, J.F., et al. Modeling of environmental effects in genome-wide association studies identifies SLC2A2 and HP as novel loci influencing serum cholesterol levels. PLoS Genet, 6, 2010, e1000798.
72. 72 Ho, M.M., Yoganathan, P., Chu, K.Y., et al. Diabetes genes identified by genome-wide association studies are regulated in mice by nutritional factors in metabolically relevant tissues and by glucose concentrations in islets. BMC Genet, 14, 2013, 10.
73. 73 Lusk, C.M., Dyson, G., Clark, A.G., et al. Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the atherosclerosis risk in communities study. Hum Genet 133 (2014), 1105–1116.
74. 74 Scriver, C.R., The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat 28 (2007), 831–845.
75. 75 Casey, L., Caring for children with phenylketonuria. Can Fam Physician 59 (2013), 837–840.
76. 76 Robert, M., Rocha, J.C., van Rijn, M., et al. Micronutrient status in phenylketonuria. Mol Genet Metab 110 Suppl (2013), S6–S17.
77. 77 Cancer Intervention and Surveillance Modeling Network, 2014 http://cisnet.cancer.gov/ Accessed June 23, 2014.
78. 78 Hiatt, R.A., Epidemiology: key to translational, team, and transdisciplinary science. Ann Epidemiol 18 (2008), 859–861.
79. 79 Cancer Control Framework and Synthesis Rationale, 2014 http://cancercontrol.cancer.gov/od/about.html Accessed June 23, 2014.
80. 80 Poincare, H., The Foundations of Science: Science and Hypothesis, The Value of Science, Science and Method. Cattell, J.M., (eds.), 1913, The Science Press, New York and Garrison NY, 127.
81. 81 Hiatt, R., Samet, J., Ness, R.B., The role of the epidemiologist in clinical and translational science. Ann Epidemiol 16 (2006), 409–410.
82. 82 Berkman, L.F., Social epidemiology: social determinants of health in the United States: are we losing ground?. Annu Rev Public Health 30 (2009), 27–41.
83. 83 Landrigan, P.J., Children's environmental health: a brief history. Acad Pediatr 16 (2016), 1–9.
84. 84 Gurtler, R.E., Yadon, Z.E., Eco-bio-social research on community-based approaches for Chagas disease vector control in Latin America. Trans R Soc Trop Med Hyg 109 (2015), 91–98.
85. 85 Gonzalez, J.P., Lambert, G., Legand, A., et al. Toward a transdisciplinary understanding and a global control of emerging infectious diseases. J Infect Dev Ctries 5 (2011), 903–905.
86. 86 Barrow, T.M., Michels, K.B., Epigenetic epidemiology of cancer. Biochem Biophy Res Commun 455 (2014), 70–83.
87. 87 Marsit, C.J., Influence of environmental exposure on human epigenetic regulation. J Exp Biol 218 (2015), 71–79.
88. 88 Ciesielski, T.H., Marsit, C.J., Williams, S.M., Maternal psychiatric disease and epigenetic evidence suggest a common biology for poor fetal growth. BMC Pregnancy Childbirth, 15, 2015, 192.
89. 89 Ogino, S., Campbell, P.T., Nishihara, R., et al. Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control 26 (2015), 959–972.
90. 90 Nishi, A., Milner, D.A. Jr., Giovannucci, E.L., et al. Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn 16 (2016), 11–23.
91. 91 Hiatt, R.A., Invited commentary: driving for further evolution. Am J Epidemiol 181 (2015), 459–462.
92. 92 Huang, X., Bruce, B., Buchan, A., et al. No-boundary thinking in bioinformatics research. BioData Min, 6, 2013, 19.
93. 93 Clinical and Translational Science Awards, 2014 https://www.ctsacentral.org/ Accessed June 23, 2014.
94. 94 Vogel, A.L., Stipelman, B.A., Hall, K.L., et al. Pioneering the transdisciplinary team science approach: lessons learned from National Cancer Institute Grantees. J Transl Med Epidemiol, 2, 2014.
95. 95 Enhancing the effectiveness of team science. Committee on the Science of Team Science. Board on Behavioral, Cognitive, and Sensory Sciences. Division of Behavioral and Social Sciences and Education. National Research Council. Cooke NJ, Hilton ML, editors. Washington DC: 2015 by the National Academy of Sciences; 2015.
96. 96 Kemp, S.P., Nurius, P.S., Preparing emerging Doctoral Scholars for transdisciplinary research: a developmental approach. J Teach Soc Work 35 (2015), 131–150.
97. 97 Lawlor, E.F., Kreuter, M.W., Sebert-Kuhlmann, A.K., et al. Methodological innovations in public health education: transdisciplinary problem solving. Am J Public Health 105 Suppl 1 (2015), S99–S103.
98. 98 Czajkowski, S.M., Lynch, M.R., Hall, K.L., et al. Transdisciplinary translational behavioral (TDTB) research: opportunities, barriers, and innovations. Translational Behav Med 6 (2016), 32–43.